Production (Stage)
MedX Health Corp
MDX.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 134.30K | 66.40K | 76.20K | 79.20K | 48.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 134.30K | 66.40K | 76.20K | 79.20K | 48.80K |
| Cost of Revenue | 82.10K | 41.40K | 36.00K | 55.50K | 47.20K |
| Gross Profit | 52.30K | 25.00K | 40.20K | 23.70K | 1.50K |
| SG&A Expenses | 193.00K | 290.00K | 487.40K | 474.00K | 377.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 370.10K | 423.50K | 614.30K | 635.70K | 514.30K |
| Operating Income | -235.80K | -357.10K | -538.10K | -556.50K | -465.50K |
| Income Before Tax | -790.00K | -508.80K | -677.00K | -687.40K | -442.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -790.00K | -508.80K | -677.00K | -687.40K | -442.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -790.00K | -508.80K | -677.00K | -687.40K | -442.10K |
| EBIT | -235.80K | -357.10K | -538.10K | -556.50K | -465.50K |
| EBITDA | -235.10K | -348.50K | -529.50K | -555.80K | -454.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 269.41M | 269.98M | 264.66M | 261.96M | 232.23M |
| Average Diluted Shares Outstanding | 269.41M | 269.98M | 264.66M | 261.96M | 232.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |